Royal Bank of Canada restated their outperform rating on shares of Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) in a report released on Wednesday morning,Benzinga reports. The firm currently has ...
Vanguard High Dividend Yield ETF is well-diversified, primarily investing in large-cap, dividend-growing stocks. See why VYM ...
If that trend continues, it's unlikely the consumer staples, energy, real estate, healthcare, or materials sectors will beat ...
Zacks.com on MSN1d
ETFs in Focus Post UnitedHealth's Mixed Q4 ResultsWall Street is suddenly uneasy about Trump's agenda, and the markets are sending him a message ...
Hosted on MSN2d
UBS Downgrades Regeneron Pharmaceuticals (REGN)Fintel reports that on January 16, 2025, UBS downgraded their outlook for Regeneron Pharmaceuticals (NasdaqGS:REGN) from Buy ...
Hosted on MSN8d
B. Riley Securities Initiates Coverage of Eton Pharmaceuticals (ETON) with Buy RecommendationFintel reports that on January 10, 2025, B. Riley Securities initiated coverage of Eton Pharmaceuticals (NasdaqGM:ETON) with ...
Madrigal Pharmaceuticals (NASDAQ:MDGL – Get Free Report)‘s stock had its “market outperform” rating reaffirmed by equities ...
Drug maker Johnson & Johnson is exploring a bid to acquire Intra-Cellular Therapies , a biopharmaceutical company, Bloomberg ...
Learn More The Vanguard Australian Shares Index ETF (ASX ... The Spartan Resources share price rose by 171.15% to finish the ...
One of the contenders for the president-general seat of Ohanaeze Ndigbo, Uche Okwukwu, in an explosive interview in Port ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback